P66Shc, a multifaceted protein linking Erk signalling, glucose metabolism, and oxidative stress

Archives of Physiology and Biochemistry

Volumn 117, Issue 3, 2011, Pages 116-124

  Natalicchio, Annalisa ^a   Tortosa, Federica ^a   Perrini, Sebastio ^a   Laviola, Luigi ^a   Giorgino, Francesco ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Erk; glucose transport; IGF I signalling; oxidative stress; Shc

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SHC; SHC1 PROTEIN, HUMAN;

ANIMAL; CONFERENCE PAPER; HUMAN; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DIABETES MELLITUS, TYPE 2; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 3; HUMANS; OXIDATIVE STRESS; SHC SIGNALING ADAPTOR PROTEINS; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 79959221661     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2011.562513     Document Type: Conference Paper

References (86)

1. Alldridge LC, Bryant CE. (2003). Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res 290:93-107. (Pubitemid 37153254)
2. Arany I, Faisal A, Nagamine Y, Safrstein RL. (2008). p66shc inhibits pro-survival epidermal growth factor receptor/ERK signalling during severe oxidative stress in mouse renal proximal tubule cells. J Biol Chem 283:6110-17.
3. Ballard VLT, Edelberg JM. (2007). Stem cells and the regeneration of the aging cardiovascular system. Circ Res 100:1116-27. (Pubitemid 46684125)
4. Biggs 3rd WH, Cavenee WK, Arden KC. (2001). Identifcation and characterization of members of the FKHR [FOXO] subclass of winged-helix transcription factors in the mouse. Mamm Genome 12:416-25. (Pubitemid 32463734)
5. Bonfni L, Migliaccio E, Pelicci G, Lanfrancone L, Pelicci PG. (1996). Not all Shc's roads lead to Ras. Trends Biochem Sci 21:257-61. (Pubitemid 26228276)
6. Brownlee M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-20. (Pubitemid 34000785)
7. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-68. (Pubitemid 29165088)
8. Camici GG, Cosentino F, Tanner FC, Lüscher TF. (2008). Te role of p66Shc deletion in age-associated arterial dysfunction and disease states. J Appl Physiol 105:1628-631.
9. Carlsson C, Borg LA, Welsh N. (1999). Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology 140:3422-8. (Pubitemid 30645397)
10. Dandona P, Mohanty P, Hamouda W, Ghanim H, Aljada A, Garg R, Kumar V. (2001). Inhibitory efect of a two day fast on reactive oxygen species (ROS) generation by leucocytes and plasma ortho-tyrosine and meta-tyrosine concentrations. J Clin Endocrinol Metab 86:2899-2902. (Pubitemid 32545759)
11. Davol PA, Bagdasaryan R, Elfenbein GJ, Maizel AL, Frackelton Jr AR. (2003). Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer. Cancer Res 63:6772-83. (Pubitemid 37322958)
12. Dijkers PF, Medema RH, Lammers JW, Koenderman L, Cofer PJ. (2000). Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 10:1201-4.
13. El-Shemerly MY, Besser D, Nagasawa M, Nagamine Y. (1997). 12-O-Tetradecanoylphorbol-13-acetate activates the Ras/extracellular signal-regulated kinase [ERK] signalling pathway upstream of SOS involving serine phosphorylation of Shc in NIH3T3 cells. J Biol Chemistry 272:30599-602. (Pubitemid 27527487)
14. Engebraaten O, Bjerkvig R, Pedersen PH, Laerum, OD. (1993). Efects of EGF, bFGF, NGF, and PDGF on cell proliferative, migratory, and invasive capacities of human brain tumour biopsies in vitro. Int J Cancer 53:209-14. (Pubitemid 23042867)
15. Faisal A, el-Shemerly M, Hess D, Nagamine Y. (2002). Serine/threonine phosphorylation of ShcA. Regulation of proteintyrosine phosphatase-pest binding and involvement in insulin signalling. J Biol Chem 277:30144-52.
16. Francia P, delli Gatti C, Bachschmid M, Martin-Padura I, Savoia C, Migliaccio E, Pelicci PG, Schiavoni M, Lüscher TF, Volpe M, et al. (2004). Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation, 110:2889-95. (Pubitemid 39473614)
17. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, et al. (2005). Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122, 221-33. (Pubitemid 41032986)
18. Graiani G, Lagrasta C, Migliaccio E, Spillmann F, Meloni M, Madeddu P, Quaini F, Padura IM, Lanfrancone L, Pelicci P, et al. (2005). Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage. Hypertension 46:433-40. (Pubitemid 41099181)
19. Gu J, Tamura M, Pankov R, Danen EH, Takino T, Matsumoto K, Yamada KM. (1999). Shc and FAK diferentially regulate cell motility and directionality modulated by PTEN. J Cell Biol 146:389-403. (Pubitemid 29369775)
20. Holt KH, Kasson BG, Pessin JE. (1996). Insulin stimulation of a MEK-dependent but ERK-independent SOS protein kinase. Mol Cell Biol 16:577-583. (Pubitemid 26029096)
21. Inoue M, Sato EF, Nishikawa M, Kira Y, Imada I, Utsumi K., Mitochondrial generation of reactive oxygen species, and its role in aerobic life. (2003). Curr Med Chem 10:2495-505. (Pubitemid 37460972)
22. Jackson JG, Yoneda T, Clark GM, Yee D. (2000). Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential. Clin Cancer Res 6:1135-9. (Pubitemid 30159377)
23. Jain SK, McVie R, Duett J, Herbst JJ. (1989). Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38:1539-43. (Pubitemid 20006678)
24. Jain SK, Kannan K, Lim G, McVie R, Bocchini Jr JA. (2002). Hyperketonemia increases tumor necrosis factor-alpha secretion in cultured U937 monocytes and type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP defciency. Diabetes 51:2287-93. (Pubitemid 34729037)
25. Jain SK, Kannan K, Lim G, Matthews-Greer J, McVie R, Bocchini Jr JA. (2003). Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes Care 26:2139-43. (Pubitemid 41184265)
26. Kao AW, Waters SB, Okada S, Pessin JE. (1997). Insulin stimulates the phosphorylation of the 66-and 52-kilodalton Shc isoforms by distinct pathways. Endocrinology, 138:2474-80. (Pubitemid 27215252)
27. Kim CS, Jung SB, Naqvi A, Hofman TA, DeRicco J, Yamamori T, Cole MP, Jeon BH, Irani K. (2008). P53 impairs endothelium-dependent vasomotor function through transcriptional upregulation of p66Shc. Circ Res 103:1441-50.
28. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh, DA. (1997). Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137:481-92. (Pubitemid 27181299)
29. Koch OR, Fusco S, Ranieri SC, Maulucci G, Palozza P, Larocca LM, Cravero AA, Farré SM, De Spirito M, Galeotti T, et al. (2008). Role of the life span determinant P66[shcA] in ethanol-induced liver damage. Lab Invest 88:750-60. (Pubitemid 351896640)
30. Kops GJ, Dansen TB., Polderman PE, Saarloos I, Wirtz KW, Cofer PJ, Huang TT, Bos JL, Medema RH, Burgering BM. (2002). Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419:316-32.
31. Lai KM, Pawson T. (2000). Te ShcA phosphotyrosine docking protein sensitizes cardiovascular signalling in the mouse embryo. Genes Dev 14:1132-45. (Pubitemid 30324426)
32. Le S, Connors TJ, Maroney AC (2001). c-Jun N-terminal Kinase specifcally phosphorylates p66 ShcA at serine 36 in response to ultraviolet irradiation. J Biol Chem 276:48332-6.
33. Lebiedzinska M, Duszynski J, Rizzuto R, Pinton P, Wieckowski MR. (2009). Age-related changes in levels of p66Shc and serine 36-phosphorylated p66Shc in organs and mouse tissues. Arch Biochem Biophys 486:73-80.
34. Lee MS, Igawa T, Chen SJ, Van Bemmel D, Lin JS, Lin FF, Johansson SL, Christman JK, Lin MF. (2004). p66Shc protein is upregulated by steroid hormones in hormone-sensitive cancer cells and in primary prostate carcinomas. Int J Cancer, 108:672-8. (Pubitemid 38076398)
35. Li PF, Dietz R, von Harsdorf R. (1999). p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J 18:6027-36. (Pubitemid 29515679)
36. Luzi L, Confalonieri S, Di Fiore PP, Pelicci PG. (2000). Evolution of Shc functions from nematode to human. Curr Opin Genet Dev 10:668-74.
37. Maytin M, Leopold J, Loscalzo J. (1999). Oxidant stress in vasculature. Curr Atheroscler Rep 1:156-64.
38. Menini S, Amadio L, Oddi G, Ricci C, Pesce C, Pugliese F, Giorgio M, Migliaccio E, Pelicci P, Iacobini C, et al. (2006). Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress. Diabetes 55:1642-50. (Pubitemid 44324116)
39. Migliaccio E, Mele S, Salcini AE, Pelicci G, Lai KM, Superti-Furga G, Pawson T, Di Fiore PP, Lanfrancone L, Pelicci PG. (1997). Opposite efects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J 16:706-16 (Pubitemid 27089518)
40. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolf PP, Lanfrancone L, Pelicci, PG. (1999). Te p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309-13. (Pubitemid 129516269)
41. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. (2000). Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 85:2970-73. (Pubitemid 32269184)
42. Nakamura T, Muraoka S, Sanokawa R, Mori N. (1998). N-Shc and Sck, two neuronally expressed Shc adapter homologs. Teir diferential regional espression in the brain and roles in neurotrophin and Src signalling. J Biol Chem 273:6960-67. (Pubitemid 28160362)
43. Napoli C, Martin-Padura I, de Nigris F, Giorgio M, Mansueto G, Somma P, Condorelli M, Sica G, De Rosa G, Pelicci P. (2003). Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci USA 100:2112-16. (Pubitemid 36254582)
44. Natalicchio A, Laviola L, De Tullio C, Renna LA, Montrone C, Perrini S, Valenti G, Procino G, Svelto M, Giorgino F. (2004). Role of p66SHC isoform in IGF-I receptor signal through MEK/ERK and regulation of actin cytoskeleton in rat myoblasts. J Biol Chem 279:43900-9. (Pubitemid 39390698)
45. Natalicchio A, De Stefano F, Perrini S, Laviola L, Cignarelli A, Caccioppoli C, Quagliara A, Melchiorre M, Leonardini A, Conserva A, et al. (2009). Involvement of the p66Shc protein in glucose transport regulation in skeletal muscle myoblasts. Am J Physiol Endocrinol Metab 296:E228-37
46. Nemoto S, Finkel T. (2002). Redox regulation of forkhead proteins through a p66shc-dependent signalling pathway. Science 295:2450-52. (Pubitemid 34270258)
47. Nemoto S, Combs CA, French S, Ahn BH, Fergusson MM, Balaban RS, Finkel T. (2006). Te mammalian longevity associated gene product p66shc regulates mitochondrial metabolism. J Biol Chem 281:10555-60. (Pubitemid 43864596)
48. Nishikawa T, Edelstein D, Brownlee M. (2000). Te missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl 77:S26-30
49. Nolan MK, Jankowska L, Prisco M, Xu S, Guvakova MA, Surmacz E. (1997). Diferential roles of IRS-1 and SHC signalling pathways in breast cancer cells. Int J Cancer 72:828-34. (Pubitemid 27431527)
50. Okada S, Kao AW, Ceresa BP, Blaikie P, Margolis B, Pessin JE. (1997). Te 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway. J Biol Chem 272:28042-9. (Pubitemid 27473612)
51. Omata W, Shibata H, Li L, Takata K, Kojima I. (2000). Actin flaments play a critical role in insulin-induced exocytolytic recruitment but not in endocytosis of GLUT4 in isolated rat adipocyres. Biochem J 346:321-8. (Pubitemid 30148116)
52. Orlando MR, Laviola L, Tortosa F, Incalza MA, Melchiorre M, Leonardini A, Perrini S, Natalicchio A, Giorgino F. (2010). Inolvement of p66Shc in TNFα-induced endothelial dysfunction. Diabetes 59(Suppl 1):A241.
53. Orr, WC, Sohal RS. (1994). Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 263:1128-30. (Pubitemid 24105957)
54. Orsini F, Migliaccio E, Moroni M, Contursi C, Raker VA, Piccini D, Martin-Padura I, Pelliccia G, Trinei M, Bono M, et al. (2004). Te life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J Biol Chem 279:25689-95. (Pubitemid 38756832)
55. Pacini S, Pellegrini M, Migliaccio E, Patrussi L, Ulivieri C, Ventura A, Carraro F, Naldini A, Lanfrancone L, Pelicci P, et al. (2004). p66SHC promotes apoptosis and antagonizes mitogenic signalling in T cells. Mol Cell Biol 24:1747-57. (Pubitemid 38167095)
56. Pagnin E, Fadini G, de Toni R, Tiengo A, Calò L, Avogaro A. (2005). Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress. J Clin Endocrinol Metab 90:1130-36. (Pubitemid 40279244)
57. Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Grignani F, Pawson T, Pelicci PG. (1992). A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell, 70:93-104.
58. Pelicci G, Giordano S, Zhen Z, Salcini AE, Lanfrancone L, Bardelli A, Panayotou G, Waterfeld MD, Ponzetto C, Pelicci PG, et al. (1995). Te motogenic and mitogenic responses to HGF are amplifed by the Shc adaptor protein. Oncogene 10:1631-8.
59. Pelicci G, Dente L, De Giuseppe A, Verducci-Galletti B, Giuli S, Mele S, Vetriani C, Giorgio M, Pandolf PP, Cesareni G, et al. (1996). A family of Shc related proteins with conserved PTB, CH1 and SH2 regions. Oncogene 13:633-64.
60. Perrini S, De Stefano F, Natalicchio A, Tortosa F, Peschechera A, Cignarelli A, Ficarella R, Melchiorre M, Losurdo F, Laviola L, et al. (2010). Genetic mutation of p66Shc protein at Ser36 prevents oxidative stress human liver cells. Diabetes 59(Suppl 1):A24.
61. Pinton P, Rimessi A, Marchi S, Orsini F, Migliaccio E, Giorgio M, Contursi C, Minucci S, Mantovani F, Wieckowski MR, et al. (2007). Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial efects of the life-span determinant p66Shc. Science 315:659-63. (Pubitemid 46214712)
62. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. (1997). A model for p53-induced apoptosis. Nature 389:300-5. (Pubitemid 27406646)
63. Ratner S, Patrick P, Bora G. (1992). Lymphocyte development of adherence and motility in extracellular matrix during IL-2 stimulation. Te Journal of Immunology, 149, 681-88.
64. Ravichandran KS. (2001). Signalling via Shc family adapter proteins. Oncogene 20:6322-30. (Pubitemid 32977841)
65. Rescan C, Coutant A, Talarmin H, Teret N, Glaise D, Guguen-Guillouzo C, Bafet G. (2001). Mechanism in the sequential control of cell morphology and S phase entry by epidermal growth factor involves distinct MEK/ERK activations. Mol Biol Cell 12:725-38. (Pubitemid 33052024)
66. Sastre J, Pallardo FV, Vina J. (2003). Te role of mitochondrial oxidative stress in aging. Free Radic Biol Med 35:1-8. (Pubitemid 36782332)
67. Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P, Green DR. (2000). P53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J Biol Chem 275:7337-42. (Pubitemid 30146286)
68. Smith WW, Norton DD, Gorospe M, Jiang H, Nemoto S, Holbrook NJ, Finkel T, Kusiak JW. (2005). Phosphorylation of p66Shc and forkhead proteins mediates Aβ toxicity. J Cell Biol 169:331-39. (Pubitemid 40656570)
69. Spranger J, Kroke A, Mohlig M, Hofmann K, Bergmann MM, Ristow M, Boeing H, Pfeifer AF. (2003). Infammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812-17. (Pubitemid 36323590)
70. Stevenson MA, Pollock SS, Coleman CN, Calderwood SK. (1994). X-irradiation, phorbol esters, and H2O2 stimulate mitogen-activated protein kinase activity in NIH-3T3 cells through the formation of reactive oxygen intermediates. Cancer Res 54:12-15. (Pubitemid 24042078)
71. Stevenson LE, Frackelton Jr AR. (1998). Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells:correlation with ErbB2 and p66 Shc expression. Breast Cancer Res Treat 49:119-28. (Pubitemid 28279589)
72. Tang ED, Nuñez G, Barr FG, Guan KL. (1999). Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 274:16741-6.
73. Taylor WR, Greenberg AH, Turley EA, Wright JA. (1993). Cell motility, invasion, and malignancy induced by overexpression of K-FGF or bFGF. Exp Cell Res 204, 295-301. (Pubitemid 23200193)
74. Trinei M, Giorgio M, Cicalese A, Barozzi S, Ventura A, Migliaccio E, Milia E, Padura IM, Raker VA, Maccarana M, et al. (2002). A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 21:3872-8. (Pubitemid 34620855)
75. Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A, Dandona P. (2003). Elevation of free fatty acids induces infammation and impairs vascular reactivity in healthy subjects. Diabetes 52:2882-7. (Pubitemid 37466856)
76. Tsakiridis T, Vranic M, Klip A. (1994). Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane. J Biol Chem 269:29934-42. (Pubitemid 24365162)
77. Veeramani S, Igawa T, Yuan TC, Lin FF, Lee MS, Lin JS, Johansson SL, Lin MF. (2005). Expression of p66 [Shc] protein correlates with proliferation of human prostate cancer cells. Oncogene 24:7203-12. (Pubitemid 41679282)
78. Ventura A, Luzi L, Pacini S, Baldari CT, Pelicci PG. (2002). Te p66Shc longevity gene is silenced through epigenetic modifcations of an alternative promoter. J Biol Chem 277:22370-76. (Pubitemid 34967205)
79. Ventura A, Maccarana M, Raker VA, Pelicci PG. (2004). A cryptic targeting signal induces isoform-specifc localization of p46Shc to mitochondria. J Biol Chem 279:2299-306. (Pubitemid 38084503)
80. Wang Q, Bilan PJ, Tsakiridis T, Hinek A, Klip A. (1998). Actin flament participate in the relocalization of phosphatidyl 3-kinase to glucose transporter-containing compartments and in the stimulation of glucose uptake in 3T3-L1 adipocytes. Biochem J 331:917-28. (Pubitemid 28211918)
81. Xi G, Shen X, Clemmons DR. (2010). p66shc inhibits insulin-like growth factor-I signalling via direct binding to Src through its polyproline and Src homology 2 domains, resulting in impairment of Src kinase activation. J Biol Chem 285:6937-51.
82. Xie Y Hung MC. (1996). p66Shc isoform down-regulated and not required for HER-2/neu signalling pathway in human breast cancer cell lines with HER-2/neu overexpression. Biochem Biophys Res Comm 221:140-45.
83. Yamamoto Y, Yoshimasa Y, Koh M, Suga J, Masuzaki H, Ogawa Y Hosoda K, Nishimura H, Watanabe Y, Inoue G, et al. (2000). Constitutively active mitogen-activated protein kinase kinase increases GLUT1 expressions and recruits both GLUT1 and GLUT4 at the cell surface in 3T3-L1 adipocytes. Diabetes 49:332-9. (Pubitemid 30131777)
84. Yang CP, Horwitz SB. (2000). Taxol mediates serine phosphorylation of the 66-kDa Shc isoform. Cancer Res 60:5171-8.
85. Yang CP, Horwitz SB. (2002). Distinct mechanisms of taxol-induced serine phosphorylation of the 66-kDa Shc isoform in A549 and RAW 264.7 cells. Biochim Biophys Acta 1590:76-83. (Pubitemid 34626770)
86. Zaccagnini G, Martelli F, Fasanaro P, Magenta A, Gaetano C, Di Carlo A, Biglioli P, Giorgio M, Martin-Padura I, et al. (2004). p66ShcA modulates tissue response to hindlimb ischemia. Circulation 109:2917-23. (Pubitemid 38780308)